cMet agonistic antibody attenuates apoptosis in ischaemia‐reperfusion–induced kidney injury

Acute kidney injury (AKI) is a very common complication with high morbidity and mortality rates and no fundamental treatment. In this study, we investigated whether the hepatocyte growth factor (HGF)/cMet pathway is associated with the development of AKI and how the administration of a cMet agonisti...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Cell Mol Med
Päätekijät: An, Jung Nam, Li, Lilin, Lee, Junghun, Yu, Seung‐Shin, Lee, Jeonghwan, Kim, Yong Chul, Kim, Dong Ki, Oh, Yun Kyu, Lim, Chun Soo, Kim, Yon Su, Kim, Sunyoung, Yang, Seung Hee, Lee, Jung Pyo
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2020
Aiheet:
Original Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7214182/
https://ncbi.nlm.nih.gov/pubmed/32239661
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.15225
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia